AERI

Aerie Pharmaceuticals, Inc.
AERI

Overview Fund Activity
Delisted

AERI was delisted on the 18th of November, 2022.

Back to rankings

167 hedge funds and large institutions have $1.09B invested in Aerie Pharmaceuticals, Inc. in 2019 Q3 according to their latest regulatory filings, with 41 funds opening new positions, 77 increasing their positions, 31 reducing their positions, and 40 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
167
Holders Change
–
Holders Change %
0%
% of All Funds
3.67%
Holding in Top 10
5
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-28.57%
% of All Funds
0.11%
New
41
Increased
77
Reduced
31
Closed
40
Calls
$16.9M
Puts
$7.68M
Net Calls
+$9.2M
Net Calls Change
+$5.17M

Top Buyers

1
PHS
PFM Health Sciences
California
$35.2M
2
DM
Deerfield Management
New York
$87.8M
3
Point72 Asset Management
Point72 Asset Management
Connecticut
$27.2M
4
LCS
Levin Capital Strategies
New York
$22.9M
5
KCM
Kingdon Capital Management
New York
$15.6M

Top Sellers

1
CCM
Consonance Capital Management
New York
$0
2
PAMU
Pictet Asset Management (UK)
United Kingdom
$0
3
Adage Capital Partners
Adage Capital Partners
Massachusetts
$7.5M
4
Neuberger Berman Group
Neuberger Berman Group
New York
$0
5
Jennison Associates
Jennison Associates
New York
$602K
Name Holding Trade Value Shares
Change 		Shares
Change %
PCM
201
Prelude Capital Management
New York
– -$7K -236 Closed
S
202
SignatureFD
Georgia
– -$4K -125 Closed
PCP
203
Proficio Capital Partners
Massachusetts
– -$2K -56 Closed
PHK
204
Point72 Hong Kong
Hong Kong
– -$1K -30 Closed
PCG
205
Private Capital Group
Connecticut
– -$1K -10 Closed
5 6 7 8
9